Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

People blinded by degenerative eye disease could have some of their sight restored by the first commercial retinal prosthesis. A camera mounted on a pair of glasses feeds an image to an array of 60 electrodes implanted in the wearer’s retina. Although the resulting vision is limited, it’s good enough for recognizing simple objects, finding doors and windows, and, in some cases, even reading large print.

Product: Argus II
Cost: $115,000
Availability: Now
Source: www.2-sight.eu
Company: Second Sight

Credit: Credit: Second Sight

Tagged: Biomedicine, Second Sight

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me